BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Myostatin (MSTN; GDF8)

February 18, 2016 8:00 AM UTC

Mouse studies suggest the anti-MSTN antibody NINA 842 could help treat sarcopenia. In aged mice, NINA 842 decreased intramuscular levels of triglycerides, and increased lean body mass and grip strength compared with vehicle. Next steps by Atara Biotherapeutics Inc. could include clinical testing in sarcopenia patients...